Mabpharm LtdMabpharm Ltd - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

Alternative corporations in the scoring industry group for Mabpharm Ltd are shownin the table. This SDG assessment for Mabpharm Ltd represents its transparency towards the UN Sustainable Development Goals. This webpage of Mabpharm Ltd was prepared by All Street Sevva using proprietary AI.

Mabpharm Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.5; made up of an environmental score of 1.6, social score of 4.8 and governance score of 4.0.

SDG Transparency Score for Mabpharm Ltd 

3.5

Low Impact
0 - 3
Medium
4 - 6
High
7 - 10
Last Score Update: 2023-07-01
What drives the score for Mabpharm Ltd 
1.6

Environmental

4.8

Social

4.0

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
.........
1575Vitality Biopharma Inc
3.6
Medium
1575Zhejiang East Asia Pharmaceutical Co Ltd
3.6
Medium
1617Mabpharm Ltd
3.5
Medium
1617Anika Therapeutics Inc
3.5
Medium
1617Aerovate Therapeutics Inc
3.5
Medium
.........
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Mabpharm Ltd have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Mabpharm Ltd disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Mabpharm Ltd report the average age of the workforce?

LockedSign up for free to unlock

Does Mabpharm Ltd reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Mabpharm Ltd disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Mabpharm Ltd disclose cybersecurity risks?

LockedSign up for free to unlock

Does Mabpharm Ltd offer flexible work?

LockedSign up for free to unlock

Does Mabpharm Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Mabpharm Ltd disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Mabpharm Ltd conduct supply chain audits?

LockedSign up for free to unlock

Does Mabpharm Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Mabpharm Ltd conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Mabpharm Ltd disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Mabpharm Ltd disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Mabpharm Ltd disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Mabpharm Ltd disclose water use targets?

LockedSign up for free to unlock

Does Mabpharm Ltd have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Mabpharm Ltd have a product recall in the last two years?

LockedSign up for free to unlock

Does Mabpharm Ltd disclose incidents of discrimination?

LockedSign up for free to unlock

Does Mabpharm Ltd allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Mabpharm Ltd issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Mabpharm Ltd disclose parental leave metrics?

LockedSign up for free to unlock

Does Mabpharm Ltd disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Mabpharm Ltd disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Mabpharm Ltd disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Mabpharm Ltd support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Mabpharm Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Mabpharm Ltd reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Mabpharm Ltd involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Mabpharm Ltd disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Mabpharm Ltd disclose its waste policy?

LockedSign up for free to unlock

Does Mabpharm Ltd report according to TCFD requirements?

LockedSign up for free to unlock

Does Mabpharm Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Mabpharm Ltd disclose energy use targets?

LockedSign up for free to unlock

Does Mabpharm Ltd disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Mabpharm Ltd have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Mabpharm Ltd
These potential risks are based on the size, segment and geographies of the company.

Mabpharm Limited, a biopharmaceutical company, engages in research, development, and production of drugs and biosimilar drugs for allergic diseases, cancers, and autoimmune diseases in China. Its products under the Phase III clinical trial include CMAB007, a recombinant humanized anti-IgE monoclonal antibody for treatment of asthma patients; CMAB009, a recombinant anti-EGFR chimeric monoclonal antibody for the first-line treatment of metastatic colorectal cancer; CMAB008, a recombinant anti-TNF-alpha chimeric monoclonal antibody for moderate to severe active rheumatoid arthritis; and CMAB807 for osteoporosis indications. The company is also developing CMAB819 that is in Phase I clinical trial for the treatment of metastatic non-small cell lung cancer, hepatocellular carcinoma, and head and neck squamous cell carcinomas; CMAB807X for the treatment of tumor bone metastasis; and CMAB809 that is in Phase I clinical trial for the treatment of HER2 overexpressing breast cancer and metastatic gastric cancer. In addition, its products under the pre-clinical stage include CMAB810 for the treatment of breast cancer; CMAB816 for the treatment of periodic fever syndrome, lung cancer, and systemic juvenile idiopathic arthritis; CMAB017 for the treatment of KRAS wild-type colorectal cancer; CMAB015, a biosimilar candidate for secukinumab to treat plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis; CMAB018, a biosimilar candidate for mepolizumab, for the treatment of asthma and eosinophilic granulomatous polyangiitis; and CMAB022 for the treatment of inflammatory diseases. The company also involved in research and development, technical consulting, technology transfer, and technical services of biological products, diagnostic reagents, chemical biological reagents, and drugs. The company was incorporated in 2018 and is headquartered in Taizhou, the People's Republic of China.

Sorry!

Failed to process!